Patents | Intellepedia

Announcement: Patent and Trademark Agent Examinations 2025 by Indian IP Office

The Indian IP Office has scheduled the Patent and Trademark Agent Examinations for January 2025. This announcement details eligibility, exam format, and inclusivity measures, inviting aspiring professionals including persons with disabilities to apply.

‘Controller under an obligation to inform inventor’ says Madras High Court

The Madras High Court stressed that patent Controllers are obliged to provide detailed reasoning for refusals, enabling inventors to understand the grounds for rejection. The Court set aside two refusal orders and ordered fresh consideration, reinforcing the importance of transparency and due process in Indian patent law.

Delhi High Court Reverses Patent Office Decision: Honeywell’s Amendments Upheld

The Delhi High Court overturned the Patent Office’s refusal of Honeywell’s patent amendments, holding that the changes were within the scope of the original claims. This ruling affirms the importance of fair and thorough examination of patent applications under Indian law.

Indian Patent and Design Statistics 2024 (June 7th to 14th)

The report analyses Indian patent and design statistics for the week of 7th to 14th June 2024, including city-wise publication and grant trends. It offers factual insights into patent and industrial design activity, based on official data and objective analysis.

Inventive Step Assessment: To be Anchored in Knowledge of a Person with Ordinary Skill on the Priority Date

The Delhi High Court’s decision highlights the requirement for an objective inventive step assessment anchored in the knowledge of a person skilled in the art at the priority date. The ruling emphasises the need for detailed analysis and avoidance of hindsight in patent examinations.

Indian Patent and Design Statistics 2024 (May 31st to June 7th)

The report analyses Indian patent and design statistics for 31 May to 7 June 2024, with city-wise and yearly data on applications, grants, and registrations. It provides a factual overview for professionals seeking updated intellectual property trends in India.

Boehringer secures Patent Injunction for its Diabetes Drug – Empagliflozin

The Himachal Pradesh High Court has granted Boehringer Ingelheim an interim injunction against Eris Lifesciences, preventing the manufacture and sale of Empagliflozin during the suit. The case provides insights into the judicial approach towards pharmaceutical patent disputes in India.

Indian Patent and Design Statistics 2024 (May 24th to 31st)

This report analyses Indian patent and design statistics for 24th to 31st May 2024, highlighting weekly and yearly trends, city-wise data, and industrial design registrations. The information is compiled by BananaIP’s expert team with a focus on clarity and factual accuracy.

Patent examination should not kill the scientific temper of an inventor

The Madras High Court set aside the rejection of Industeel France’s patent application, stressing the need for fair and consistent patent examination. The judgment highlights the importance of protecting inventors’ scientific temper and ensuring time-bound decisions under Indian patent law.

New claims, Old claims, and Claim Amendments: Section 59 of the Patents Act

This post examines a Madras High Court ruling on Section 59 of the Patents Act regarding patent claim amendments. The Court clarified procedural requirements and applicant rights during the patent examination process in India.